Scholars Central

Brief reportPublished 7 Jul 2016

Imaging of pancreatic b-cell mass by PET

Authors: Gary W Cline

Diabetes Management

Volume 2 · Issue 2 · Pages 111

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Success in the noninvasive and quantitative imaging of pancreatic islet b-cell mass (BCM) has been made possible by the inherent sensitivity of PET and the development of radiotracers for b-cell enriched peptide targets. This article briefly discusses the methodological considerations that can impact upon the accuracy of measuring BCM, and approaches to optimize BCM measurements in the face of these potential limitations. The current status of two peptide receptors that show promise for imaging BCM will be discussed: glucagon-like peptide-1 receptor and vesicular monoamine transporter type 2.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiabetes Management
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Gary W Cline”